Sandbox:Sahar: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
No edit summary |
||
Line 6: | Line 6: | ||
! Preferably combined with | ! Preferably combined with | ||
|- | |- | ||
| [[Thiazide diuretics]] || [[Chlorthalidone]] || 12.5, 12.5-25|| [[Heart failure]], [[systolic hypertension|isolated systolic hypertension]], black population|| [[ACE inhibitors]], [[ARBs]], [[calcium channel blockers]] | | rowspan="4" | [[Thiazide diuretics]] || [[Chlorthalidone]] || 12.5, 12.5-25|| rowspan="4" | [[Heart failure]], [[systolic hypertension|isolated systolic hypertension]], black population|| rowspan="4" | [[ACE inhibitors]], [[ARBs]], [[calcium channel blockers]] | ||
|- | |- | ||
|[[Hydrochlorothiazide]] || 12.5-25, 25-100 | |||
|- | |- | ||
|[[Bendroflumethiazide]] || 5, 10 | |||
|- | |- | ||
|[[Indapamide]] || 1.25, 1.25-2.5 | |||
|- | |- | ||
| [[ACE inhibitors]] || [[Enalapril]] || 5, 20|| [[Left ventricular hypertrophy]], [[atherosclerosis]], [[renal insufficiency]], previous [[myocardial infarction]], [[heart failure]], [[atrial fibrillation]] (prevention), [[peripheral artery disease]], [[metabolic syndrome]], [[diabetes mellitus]]|| [[Calcium channel blockers]], [[thiazide diuretics]] | | rowspan="3" | [[ACE inhibitors]] || [[Enalapril]] || 5, 20|| rowspan="3" | [[Left ventricular hypertrophy]], [[atherosclerosis]], [[renal insufficiency]], previous [[myocardial infarction]], [[heart failure]], [[atrial fibrillation]] (prevention), [[peripheral artery disease]], [[metabolic syndrome]], [[diabetes mellitus]]|| rowspan="3" | [[Calcium channel blockers]], [[thiazide diuretics]] | ||
|- | |- | ||
|[[Lisinopril]] || 10, 40 | |||
|- | |- | ||
|[[Captopril]] || 50, 150-200 | |||
|- | |- | ||
| [[ARBs]] || [[Candesartan]] || 4, 12-32|| [[Left ventricular hypertrophy]], [[renal insufficiency]], previous [[myocardial infarction]], [[heart failure]], [[atrial fibrillation]] (prevention), [[metabolic syndrome]], [[diabetes mellitus]]|| [[Calcium channel blockers]], [[thiazide diuretics]] | | rowspan="5" | [[ARBs]] || [[Candesartan]] || 4, 12-32|| rowspan="5" | [[Left ventricular hypertrophy]], [[renal insufficiency]], previous [[myocardial infarction]], [[heart failure]], [[atrial fibrillation]] (prevention), [[metabolic syndrome]], [[diabetes mellitus]]|| rowspan="5" | [[Calcium channel blockers]], [[thiazide diuretics]] | ||
|- | |- | ||
|[[Losartan]] || 50, 100 | |||
|- | |- | ||
|[[Valsartan]] || 40-80, 160-320 | |||
|- | |- | ||
|[[Eprosartan]] || 400, 600-800 | |||
|- | |- | ||
|[[Irbesartan]] || 75, 300 | |||
|- | |- | ||
| [[Beta blockers]] || [[Atenolol]] || 25-50, 100|| | | rowspan="2" | [[Beta blockers]] || [[Atenolol]] || 25-50, 100|| rowspan="2" | Previous [[myocardial infarction]], [[atrial fibrillation]] (prevention and ventricular rate control), [[heart failure]], [[Chronic stable angina|angina pectoris]], [[aortic aneurysm]], [[pregnancy]]|| rowspan="2" | [[Thiazide diuretics]] (with limitations)<br>'''Only [[Calcium channel blocker#Dihydropyridine|dihydropyridine calcium channel blockers]] should be combined with [[beta blockers]]''' | ||
|- | |- | ||
|[[Metoprolol succinate]] || 50, 100-200 | |||
|- | |- | ||
| [[Calcium channel blockers]]|| [[Amlodipine]] || 2.5, 10|| [[Left ventricular hypertrophy]], [[pregnancy]] ([[nifedipine]]), previous [[myocardial infarction]], [[atrial fibrillation]] ([[verapamil]], [[diltiazem]]), [[metabolic syndrome]], [[peripheral artery disease]], [[atherosclerosis]], [[Chronic stable angina|angina pectoris]], [[systolic hypertension|isolated systolic hypertension]], black population|| [[ACE inhibitors]], [[ARBs]], [[thiazide diuretics]] | | rowspan="3" | [[Calcium channel blockers]]|| [[Amlodipine]] || 2.5, 10|| rowspan="3" | [[Left ventricular hypertrophy]], [[pregnancy]] ([[nifedipine]]), previous [[myocardial infarction]], [[atrial fibrillation]] ([[verapamil]], [[diltiazem]]), [[metabolic syndrome]], [[peripheral artery disease]], [[atherosclerosis]], [[Chronic stable angina|angina pectoris]], [[systolic hypertension|isolated systolic hypertension]], black population|| rowspan="3" | [[ACE inhibitors]], [[ARBs]], [[thiazide diuretics]] | ||
|- | |- | ||
|[[Diltiazem extended release]] || 120-180, 360 | |||
|- | |- | ||
|[[Nitrendipine]] || 10, 20 | |||
|- | |- | ||
|} | |} |